Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
726
McCormick & Company Non-Voting
MKC
$12.1B
| $19.3M | 0.03% |
385,600
+44,600
| +13% | +$2.26M |
2015 Q4
3 quarters
|
|
727
Insulet
PODD
$9.35B
| $19.3M | 0.03% |
470,400
-150,492
| -24% | -$5.95M |
2015 Q4
3 quarters
|
|
|
MTSC
728
DELISTED
MTS Systems Corp
MTSC
| $19.2M | 0.03% |
417,318
-13,500
| -3% | -$636K |
2013 Q2
13 quarters
|
|
729
Shutterstock
SSTK
$161M
| $19.2M | 0.03% |
300,900
+82,000
| +37% | +$4.71M |
2015 Q4
3 quarters
|
|
730
Pinnacle West Capital
PNW
$12B
| $19.1M | 0.03% |
251,900
-167,000
| -40% | -$13M |
2013 Q4
11 quarters
|
|
731
TransUnion
TRU
$12.5B
| $19.1M | 0.03% |
554,100
+62,600
| +13% | +$2.1M |
2015 Q4
3 quarters
|
|
732
Culp Inc
CULP
$46.2M
| $19.1M | 0.03% |
640,729
-2,371
| -0.4% | -$70K |
2013 Q2
13 quarters
|
|
|
FSP
733
Franklin Street Properties
FSP
$34.4M
| $19.1M | 0.03% |
1,513,900
+124,000
| +9% | +$1.56M |
2014 Q3
8 quarters
|
|
|
BEAT
734
DELISTED
BioTelemetry, Inc.
BEAT
| $19.1M | 0.03% |
1,027,200
+103,568
| +11% | +$1.95M |
2013 Q2
13 quarters
|
|
|
ANAT
735
DELISTED
American National Group, Inc. Common Stock
ANAT
| $19M | 0.03% |
156,000
+6,300
| +4% | +$727K |
2013 Q2
13 quarters
|
|
|
XXIA
736
DELISTED
Ixia
XXIA
| $19M | 0.03% |
1,520,220
-162,285
| -10% | -$1.86M |
2013 Q3
12 quarters
|
|
|
UHT
737
Universal Health Realty Income Trust
UHT
$526M
| $19M | 0.03% |
300,800
+38,000
| +14% | +$2.29M |
2014 Q3
8 quarters
|
|
|
PE
738
DELISTED
PARSLEY ENERGY INC
PE
| $19M | 0.03% |
565,600
-199,100
| -26% | -$6.23M |
2015 Q1
6 quarters
|
|
739
H&R Block
HRB
$5.41B
| $18.9M | 0.03% |
816,400
-33,900
| -4% | -$793K |
2016 Q2
1 quarter
|
|
740
Healthcare Realty
HR
$5.91B
| $18.9M | 0.03% |
579,100
+337,828
| +140% | +$11.2M |
2014 Q3
8 quarters
|
|
|
TCO
741
DELISTED
Taubman Centers Inc.
TCO
| $18.9M | 0.03% |
253,800
-92,100
| -27% | -$7.11M |
2015 Q1
6 quarters
|
|
|
HMSY
742
DELISTED
HMS Holdings Corp.
HMSY
| $18.9M | 0.03% |
851,600
-60,112
| -7% | -$1.26M |
2015 Q4
3 quarters
|
|
743
AMC Entertainment Holdings
AMC
$2.68B
| $18.8M | 0.03% |
60,620
+22,120
| +57% | +$6.63M |
2014 Q4
7 quarters
|
|
744
United Rentals
URI
$65.9B
| $18.8M | 0.03% |
+240,023
| New | +$18.4M |
2016 Q3
0 quarters
|
|
|
PHH
745
DELISTED
PHH Corporation
PHH
| $18.8M | 0.03% |
1,297,900
+366,500
| +39% | +$5.38M |
2014 Q2
9 quarters
|
|
746
Stepan Co
SCL
$1.39B
| $18.7M | 0.03% |
257,300
+21,800
| +9% | +$1.46M |
2013 Q2
13 quarters
|
|
|
GTY
747
Getty Realty Corp
GTY
$1.73B
| $18.7M | 0.03% |
780,386
-26,500
| -3% | -$613K |
2014 Q2
9 quarters
|
|
|
CPE
748
DELISTED
Callon Petroleum Company
CPE
| $18.7M | 0.03% |
118,919
+59,290
| +99% | +$7.84M |
2016 Q1
2 quarters
|
|
749
TechnipFMC
FTI
$27.3B
| $18.7M | 0.03% |
845,645
-1,353,542
| -62% | -$27.4M |
2016 Q1
2 quarters
|
|
750
Enanta Pharmaceuticals
ENTA
$367M
| $18.7M | 0.03% |
701,400
+549,200
| +361% | +$12.8M |
2016 Q1
2 quarters
|
|
Similar funds
Renaissance Technologies's Q3 2016 Portfolio in Review
As of Q3 2016, Renaissance Technologies held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $1.92B of net new capital in Q3 2016, opening 413 new positions and adding to 1,833 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Renaissance Technologies's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Renaissance Technologies's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Renaissance Technologies fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Renaissance Technologies opened 413 new positions and closed 416 in Q3 2016.
- Renaissance Technologies's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.